Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses
Qiang Zou, Jin Jin, Hongbo Hu, et al.
Nature Immunology (2014) Vol. 15, Iss. 6, pp. 562-570
Open Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

Ubiquitin signaling in immune responses
Hongbo Hu, Shao‐Cong Sun
Cell Research (2016) Vol. 26, Iss. 4, pp. 457-483
Open Access | Times Cited: 417
Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond
Baris Bingol, Morgan Sheng
Free Radical Biology and Medicine (2016) Vol. 100, pp. 210-222
Closed Access | Times Cited: 281
The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors
Helei Hou, Dantong Sun, Xiaochun Zhang
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 187
Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors
Shiyao Chen, Yunqi Liu, Huchen Zhou
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4546-4546
Open Access | Times Cited: 104
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
Wei Wang, Najah Albadari, Yi Du, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 414-453
Open Access | Times Cited: 35
Emerging Potential of Therapeutic Targeting of Ubiquitin-Specific Proteases in the Treatment of Cancer
Anupama Pal, Matthew A. Young, Nicholas J. Donato
Cancer Research (2014) Vol. 74, Iss. 18, pp. 4955-4966
Open Access | Times Cited: 181
The role of ubiquitin-specific peptidases in cancer progression
Ming-Jer Young, Kai‐Cheng Hsu, Tony Eight Lin, et al.
Journal of Biomedical Science (2019) Vol. 26, Iss. 1
Open Access | Times Cited: 128
Ubiquitin enzymes in the regulation of immune responses
Petra Ebner, Gijs A. Versteeg, Fumiyo Ikeda
Critical Reviews in Biochemistry and Molecular Biology (2017) Vol. 52, Iss. 4, pp. 425-460
Open Access | Times Cited: 123
SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation
Xiaoyan Yu, Yimin Lao, Xiao-Lu Teng, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 116
Targeting Ubiquitination for Cancer Therapies
John Kenneth Morrow, Hui‐Kuan Lin, Shao‐Cong Sun, et al.
Future Medicinal Chemistry (2015) Vol. 7, Iss. 17, pp. 2333-2350
Open Access | Times Cited: 103
Regulators of Oncogenic Mutant TP53 Gain of Function
Satomi Yamamoto, Tomoo Iwakuma
Cancers (2018) Vol. 11, Iss. 1, pp. 4-4
Open Access | Times Cited: 103
p53 stability is regulated by diverse deubiquitinating enzymes
Seul‐Ki Kwon, Madhuri Saindane, Kwang‐Hyun Baek
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2017) Vol. 1868, Iss. 2, pp. 404-411
Closed Access | Times Cited: 102
USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation
Sabrina Torre, Maria J. Polyak, David Langlais, et al.
Nature Immunology (2016) Vol. 18, Iss. 1, pp. 54-63
Closed Access | Times Cited: 86
The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics
Mingjing He, Zhuan Zhou, Anil A. Shah, et al.
Cell & Bioscience (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 86
The Involvement of Ubiquitination Machinery in Cell Cycle Regulation and Cancer Progression
Tingting Zou, Zhenghong Lin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5754-5754
Open Access | Times Cited: 84
The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors
Yihan Peng, Qingchao Liao, Wei Phin Tan, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 77
Targeting ubiquitin signaling for cancer immunotherapy
Xiaofei Zhou, Shao‐Cong Sun
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 60
Deubiquitylating Enzymes in Cancer and Immunity
Jiang Ren, Peng Yu, Sijia Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 30
Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson’s disease
Pusheng Quan, Xueying Li, Yao Si, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression
Kaifeng Jin, Ya-Wei Ding, Jingtong Xu, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010964-e010964
Open Access | Times Cited: 1
Deubiquitinating enzymes in cellular signaling and disease regulation
Pranita Hanpude, Sushmita Bhattacharya, Amit Kumar Dey, et al.
IUBMB Life (2015) Vol. 67, Iss. 7, pp. 544-555
Closed Access | Times Cited: 91
USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells
Achuth Padmanabhan, Nicholes R. Candelaria, Kwong‐Kwok Wong, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Regulation of pluripotency and differentiation by deubiquitinating enzymes
B. Suresh Chander Kapali, Junwon Lee, Seokjoong Kim, et al.
Cell Death and Differentiation (2016) Vol. 23, Iss. 8, pp. 1257-1264
Open Access | Times Cited: 76
The role of MDM2 and MDM4 in breast cancer development and prevention
Sue Haupt, Reshma Vijayakumaran, Panimaya Jeffreena Miranda, et al.
Journal of Molecular Cell Biology (2017) Vol. 9, Iss. 1, pp. 53-61
Open Access | Times Cited: 73
TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability
Wei-Ting Liu, Kuo‐Yen Huang, Ming‐Chi Lu, et al.
Oncogene (2016) Vol. 36, Iss. 19, pp. 2715-2723
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top